Evidence map›Paper›PMID 34280921›Full record

ArticleBlood purification2022

Renal Resistive Index as a Predictor of Acute Kidney Injury and Mortality in COVID-19 Critically Ill Patients.

Edgar Garcia Cruz, Blanca Estela Broca Garcia, Daniel Manzur Sandoval, Rodrigo Gopar-Nieto, Francisco Javier Gonzalez Ruiz, Linda Diaz Gallardo, Claudio Ronco, Magdalena Madero, Enzo Vasquez Jimenez

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Blood purification, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06386796 (Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients Admitted to Surgical Intensive Care Unit.), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06386796 recruitingnot on this mapstarted 2024, after this paper: background citation

Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients Admitted to Surgical Intensive Care Unit.

TypeobservationalSponsorAswan UniversityRan2024 to 2026Enrolled100ConditionsAcute Kidney Injury, Critical Illness
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Cystatin C is a marker for acute kidney injury, but not for mortality among COVID-19 patients in Mexico.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Edgar Garcia CruzDepartment of Cardiovascular Critical Care, Nacional Institute of Cardiology "Ignacio Chavez", Mexico City, Mexico.
Blanca Estela Broca GarciaDepartment of Cardiology, Nacional Institute of Cardiology "Ignacio Chavez", Mexico City, Mexico.
Daniel Manzur SandovalDepartment of Cardiovascular Critical Care, Nacional Institute of Cardiology "Ignacio Chavez", Mexico City, Mexico.
Rodrigo Gopar-NietoDepartment of Cardiology, Nacional Institute of Cardiology "Ignacio Chavez", Mexico City, Mexico.
Francisco Javier Gonzalez RuizDepartment of Cardiovascular Critical Care, Nacional Institute of Cardiology "Ignacio Chavez", Mexico City, Mexico.
Linda Diaz GallardoDepartment of Pediatrics, Sanatorio Durango, Mexico City, Mexico.
Claudio RoncoDepartment of Nephrology, San Bortolo Hospital and International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy.
Magdalena MaderoDepartment of Nephrology, Nacional Institute of Cardiology "Ignacio Chavez", Mexico City, Mexico.
Enzo Vasquez JimenezDepartment of Nephrology, Nacional Institute of Cardiology "Ignacio Chavez", Mexico City, Mexico.
Instituto Nacional de Cardiología · MXDurango Institute of Technology · MXInternational Renal Research Institute of Vicenza · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) in patients with COVID-19 can be caused by multiple mechanisms. Renal resistive index (RRI) is a noninvasive instrument to evaluate kidney hemodynamics, and it is obtained by analysis of intrarenal arterial waves using Doppler ultrasound. This study aimed to determine the role of RRI in predicting AKI and adverse outcomes in critically ill patients with COVID-19.

methodsThis cross-sectional study included 65 patients with confirmed SARS-CoV-2 pneumonia admitted to the critical care unit from April 1, 2020, to June 20, 2020. Informed consent was obtained from all individual participants included in the study. Cardiac, pulmonary, and kidney ultrasonographic evaluations were performed in a protocolized way.

resultsIn this cohort, 65 patients were included, mean age was 53.4 years, 79% were male, and 35% were diabetic. Thirty-four percent of patients developed AKI, 12% required RRT, and 35% died. Of the patients who developed AKI, 68% had RRI ≥ 0.7. Also, 75% of the patients who required RRT had RRI ≥ 0.7. In the adjusted Cox model, the RRI ≥ 0.7 was associated with higher mortality (HR 2.86, 95% CI: 1.19-6.82, p = 0.01).

conclusionsCritical care ultrasonography is a noninvasive, reproducible, and accurate bedside method that has proven its usefulness. An elevated RRI may have a role in predicting AKI, RRT initiation, and mortality in patients with severe SARS-CoV-2 pneumonia.

Indexed as

Acute Kidney InjuryCOVID-19Critical IllnessCross-Sectional StudiesHumansMaleMiddle AgedProspective StudiesSARS-CoV-2Acute kidney injuryCoronavirus diseaseRenal replacement therapyRenal resistive index

Identifiers

PMID34280921
PMCPMC8339011
OpenAlexW3186974081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.